Volume 16, Issue 96 (2020)                   FSCT 2020, 16(96): 43-51 | Back to browse issues page

XML Persian Abstract Print

1- Department of Food Science, College of Agriculture, University of Tabriz
2- Department of Food Science, College of Agriculture, University of Tabriz, , peighambardoust@tabrizu.ac.ir
3- Food and Drug Laboratory Research Center, Food and Drug Organization, Ministry of Health and Medical Education,
Abstract:   (3117 Views)
Since cancer treatment has been done through chemotherapy and various drugs that are accompanied with severe side effects in addition to therapeutic properties, nowadays sscientists are investigating anticancer therapies using natural compounds such as hydrolyzed proteins and bioactive peptides with higher treatment properties and fewer side effects. In this study, for the first time, hydrolyzed proteins obtained from pepsin, proteinase k and alcalase enzymes were used to examine its cytotoxic effect on human lung adenocarcinoma cells (A549). Human lung carcinoma A549 cell lines were grown in 90% RPMI medium supplemented with 10% fetal bovine serum and 1% penstrep. Different concentrations of hydrolysates during times of 24, 48 and 72h were affected by A549 cell lines via XTT assay. Then, the cell survival ability was evaluated by XTT method. Results showed that hydrolysates produced from wheat germ protein affected the viability of cells and it depending on the enzyme applied, concentration and time. The results of IC50 were evaluated for A549 cells in the case of pepsin, alcalase and proteinase k hydrolysates at 72 h, 11.17mg/mL, 12.94mg/mL and 11.27mg/mL. These results showed that wheat germ protein hydrolysates would be used as new source of anticancer peptides and could be a replace for common cancer therapy drugs in the near future.
Full-Text [PDF 649 kb]   (1496 Downloads)    
Article Type: Brief Communication | Subject: Supplemented foods (probiotics, parabiotics ...)
Received: 2018/07/10 | Accepted: 2019/06/9 | Published: 2020/01/30

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.